124 related articles for article (PubMed ID: 15542180)
21. Stimulation of HIV gp120-specific cytolytic T lymphocyte responses in vitro and in vivo using a detoxified pertussis toxin vector.
Carbonetti NH; Tuskan RG; Lewis GK
AIDS Res Hum Retroviruses; 2001 Jun; 17(9):819-27. PubMed ID: 11429123
[TBL] [Abstract][Full Text] [Related]
22. Intracellular delivery of a cytolytic T-lymphocyte epitope peptide by pertussis toxin to major histocompatibility complex class I without involvement of the cytosolic class I antigen processing pathway.
Carbonetti NH; Irish TJ; Chen CH; O'Connell CB; Hadley GA; McNamara U; Tuskan RG; Lewis GK
Infect Immun; 1999 Feb; 67(2):602-7. PubMed ID: 9916065
[TBL] [Abstract][Full Text] [Related]
23. Improving administration regimens of CyaA-based vaccines using TRAP assays to detect antigen-specific CD8(+) T cells directly ex vivo.
Daubeuf S; Préville X; Momot M; Misseri Y; Joly E; Hudrisier D
Vaccine; 2009 Sep; 27(41):5565-73. PubMed ID: 19647811
[TBL] [Abstract][Full Text] [Related]
24. Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sites.
Osicka R; Osicková A; Basar T; Guermonprez P; Rojas M; Leclerc C; Sebo P
Infect Immun; 2000 Jan; 68(1):247-56. PubMed ID: 10603395
[TBL] [Abstract][Full Text] [Related]
25. [Immunotherapeutic efficacy of both helper T lymphocytes and cytotoxic T lymphocytes epitopes augmented dendritic cells tumor vaccine on gastric cancer].
Li Q; Zhang Y; Chen XH; Cao WX; Gu QL; Zhu ZG; Liu BY
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):148-51. PubMed ID: 16555158
[TBL] [Abstract][Full Text] [Related]
26. Induction of anti-Tat neutralizing antibodies by the CyaA vector targeting dendritic cells: influence of the insertion site and of the delivery of multicopies of the dominant Tat B-cell epitope.
Fayolle C; Davi M; Dong H; Ritzel D; Le Page A; Knipping F; Majlessi L; Ladant D; Leclerc C
Vaccine; 2010 Oct; 28(42):6930-41. PubMed ID: 20728521
[TBL] [Abstract][Full Text] [Related]
27. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.
Viehl CT; Tanaka Y; Chen T; Frey DM; Tran A; Fleming TP; Eberlein TJ; Goedegebuure PS
Breast Cancer Res Treat; 2005 Jun; 91(3):271-8. PubMed ID: 15952060
[TBL] [Abstract][Full Text] [Related]
28. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.
Saron MF; Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3314-9. PubMed ID: 9096390
[TBL] [Abstract][Full Text] [Related]
29. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
[TBL] [Abstract][Full Text] [Related]
30. The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells.
El Azami El Idrissi M; Ladant D; Leclerc C
Toxicon; 2002 Dec; 40(12):1661-5. PubMed ID: 12457876
[No Abstract] [Full Text] [Related]
31. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
Hickey FB; Brereton CF; Mills KH
J Leukoc Biol; 2008 Jul; 84(1):234-43. PubMed ID: 18401006
[TBL] [Abstract][Full Text] [Related]
32. Formulation of the adenylate cyclase toxin of Bordetella pertussis as protein-coated microcrystals.
Khosravani A; Parker MC; Parton R; Coote J
Vaccine; 2007 May; 25(22):4361-7. PubMed ID: 17434242
[TBL] [Abstract][Full Text] [Related]
33. Immunization with dendritic cells retrovirally transduced with mycobacterial antigen 85A gene elicits the specific cellular immunity including cytotoxic T-lymphocyte activity specific to an epitope on antigen 85A.
Nakano H; Nagata T; Suda T; Tanaka T; Aoshi T; Uchijima M; Kuwayama S; Kanamaru N; Chida K; Nakamura H; Okada M; Koide Y
Vaccine; 2006 Mar; 24(12):2110-9. PubMed ID: 16352377
[TBL] [Abstract][Full Text] [Related]
34. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
35. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
36. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.
Dunne A; Ross PJ; Pospisilova E; Masin J; Meaney A; Sutton CE; Iwakura Y; Tschopp J; Sebo P; Mills KH
J Immunol; 2010 Aug; 185(3):1711-9. PubMed ID: 20610650
[TBL] [Abstract][Full Text] [Related]
37. Bioengineering of
Chenal A; Ladant D
Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30037010
[TBL] [Abstract][Full Text] [Related]
38. Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes.
Tine JA; Firat H; Payne A; Russo G; Davis SW; Tartaglia J; Lemonnier FA; Demoyen PL; Moingeon P
Vaccine; 2005 Jan; 23(8):1085-91. PubMed ID: 15620483
[TBL] [Abstract][Full Text] [Related]
39. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y
J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794
[TBL] [Abstract][Full Text] [Related]
40. Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells.
Svedova M; Masin J; Fiser R; Cerny O; Tomala J; Freudenberg M; Tuckova L; Kovar M; Dadaglio G; Adkins I; Sebo P
Immunol Cell Biol; 2016 Apr; 94(4):322-33. PubMed ID: 26437769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
